Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Core Viewpoint - Nuwellis, Inc. has received U.S. Patent No. 12,280,007 for a novel self-emptying fluid bag design that enhances nursing workflow and maintains measurement accuracy in fluid management for patients with fluid overload [1][5]. Company Overview - Nuwellis, Inc. is a medical technology company focused on fluid management solutions, particularly for patients suffering from fluid overload [6]. - The company is headquartered in Minneapolis and has a wholly owned subsidiary in Ireland [6]. Patent Details - The patent was officially issued on April 22, 2025, and includes a 224-day extension to its standard term granted by the USPTO [5]. - The patented design features a siphon mechanism that allows the fluid bag to automatically empty without disconnecting from the scale, thus preserving measurement integrity [2]. Impact on Healthcare - Fluid overload is a significant complication in critically ill patients, and the new design aims to improve the accuracy and efficiency of ultrafiltration therapy [3]. - The innovation is expected to simplify routine tasks for clinicians, enhancing both care and workflow in critical care settings [4]. Future Developments - The design may be integrated into future enhancements of the Aquadex SmartFlow system, including a pediatric-focused CRRT device currently under development [4]. - This patent represents a step towards expanding Nuwellis' product portfolio and advancing innovation in fluid management [4]. Product Information - The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kg or more, whose fluid overload is unresponsive to medical management [7]. - Treatments must be administered by trained healthcare providers in clinical settings under physician prescription [7].